Heartflow (HTFL) Non Operating Income (2024 - 2025)
Heartflow's quarterly Non Operating Income came in at -$129000.0 in Q4 2025, up 71.14% year-on-year from -$75376.5 in Q4 2024, and up 62.17% quarter-over-quarter from -$341000.0 in Q3 2025.
Heartflow has reported Non Operating Income for 2 years, with the latest figure at -$129000.0 in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income rose 71.14% year-over-year to -$129000.0; the trailing twelve-month figure through Dec 2025 stood at -$1.0 million (changed N/A YoY), and the FY2025 full-year result was -$223000.0, down 232.74% from the prior year.
- Non Operating Income for Q4 2025 stood at -$129000.0, up from -$341000.0 in the prior quarter.
- The five-year high for Non Operating Income was $852000.0 in Q3 2024, with the low at -$447000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 71.66 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | -10.54 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 3.87 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | -20.65 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -815,000.00 |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.89 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 51,000.00 |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn | -129,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -129,000.00 |
| Sep 30, 2025 | -341,000.00 |
| Jun 30, 2025 | -111,000.00 |
| Dec 31, 2024 | -447,000.00 |
| Sep 30, 2024 | 852,000.00 |
| Jun 30, 2024 | -82,000.00 |